Linagliptin
| CAS No. | 668270-12-0 | Cat. No. | BCP02462 |
| Name | Linagliptin | ||
| Synonyms | BI 1356;Tradjenta;BI-1356;BI1356; | ||
| Formula | C25H28N8O2 | M. Wt | 472.54 |
| Description | Linagliptin shows a potent inhibition effect against DPP-4 in vitro and a low affinity for hERG channel and M1 receptor (IC50 295 nM). Linagliptin acts as a competitive inhibitor with a Ki of 1 nM, and also shows 10,000-fold more selectivity for DPP-4 than DPP-8, DPP-9, amino-peptidases N and P, prolyloligopeptidase, trypsin, plasmin, and thrombin, and 90-fold more selectivity than fibroblast activation protein in vitro. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | DPP | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.